Argan, Inc. (AGX): CEO sold ~$362K
Charles Edwin Iv Collins, CEO at Argan, Inc., sold ~$362K of Argan, Inc. shares.
- ~$362K
- Approx. value · 1,500 sh @ $241.50
- 21K
- Holds after · shares reported
- Traded
- Jul 29, 2025
- Filed
- Aug 29, 2025
What stands out in this filing
- The sale was 6.7% of the shares this insider held before it; the filing reports 21,006 shares afterwards.
- 1,500 shares at an average of $241.50 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 9, 2025Insider · 3 peopleInsiders: 3 sales (~$2.0M)
- Jun 10, 2025InsiderDirector sold ~$8.32M of AGX shares in the open market
- Jun 11, 2025Insider · 3 peopleInsiders: 3 sales (~$8.7M)
- Jun 12, 2025InsiderDirector sold ~$3.31M of AGX shares in the open market
- Jun 26, 2025InsiderDirector sold ~$733K of AGX shares in the open market
- Jun 27, 2025InsiderDirector sold ~$896K of AGX shares in the open market
- Jun 30, 2025InsiderDirector sold ~$1.69M of AGX shares in the open market
- Jul 29, 2025 · this disclosureInsiderCEO sold ~$362K of AGX shares in the open market
What came next
- Jul 29, 2025InsiderDirector sold ~$618K of AGX shares in the open market
- Jul 30, 2025InsiderDirector sold ~$469K of AGX shares in the open market
- Jul 31, 2025Insider · 2 peopleInsiders: 2 sales (~$1.6M)
- Sep 17, 2025InsiderDirector sold ~$625K of AGX shares in the open market
- Sep 18, 2025InsiderCEO sold ~$1.93M of AGX shares in the open market
- Sep 19, 2025Insider · 3 peopleInsiders: 3 sales (~$3.5M)
- Sep 22, 2025InsiderDirector sold ~$1.21M of AGX shares in the open market
- Sep 24, 2025InsiderCEO sold ~$1.33M of AGX shares in the open market
- Oct 8, 2025Insider · Their largest sale since 2015Director sold ~$4.08M of AGX shares in the open market
- Oct 9, 2025Insider · 1 personInsiders: 2 sales (~$1.4M)
- Oct 13, 2025InsiderCEO sold ~$2.92M of AGX shares in the open market
- Oct 15, 2025InsiderCEO sold ~$3.09M of AGX shares in the open market
- Oct 17, 2025InsiderDirector sold ~$584K of AGX shares in the open market
- Oct 20, 2025Insider · Their largest sale since 2016Director sold ~$1.91M of AGX shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Argan, Inc.
For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGX page.
Other recent filings by Charles Edwin Iv Collins, CHIEF EXECUTIVE OFFICER, GEMMA
- SEC Form 4 at Argan, Inc. (AGX)Apr 22, 2026
- SEC Form 4 at Argan, Inc. (AGX)Apr 22, 2026
- SEC Form 4 at Argan, Inc. (AGX)Oct 18, 2025
- SEC Form 4 at Argan, Inc. (AGX)Oct 15, 2025
- SEC Form 4 at Argan, Inc. (AGX)Sep 26, 2025
The full history of Charles Edwin Iv Collins, CHIEF EXECUTIVE OFFICER, GEMMA is on the profile page.
How this filing works
Explore the data
Common questions
Which Argan, Inc. (AGX) insider traded, and how much?
Charles Edwin Iv Collins, CEO at Argan, Inc., sold ~$362K of Argan, Inc. shares. 1,500 shares at $241.50.
When did it happen, and when was it made public?
Traded: Jul 29, 2025. Filed: Aug 29, 2025. That is 31 days between the two dates.
What stands out in this filing?
The sale was 6.7% of the shares this insider held before it; the filing reports 21,006 shares afterwards. 1,500 shares at an average of $241.50 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Argan, Inc. recently?
For Argan, Inc., OQRO holds 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the AGX page.
Does this mean AGX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Argan, Inc.
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordSep 23, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its AGX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
